I agree that we will get there eventually but some realistic timelines on things would be nice. I feel like they hit their timelines on the first few sections of the BLA resubmittal but other than that I can't think of anything that's been within the timeframes that they've set. At least getting to use Leronlimab after 2 other treatments would get us some sales so we wouldn't have to worry about keeping the lights on through diluting shares. The shares we approved last October just seem like a waste at this point.